Paloma Partners’s Annovis Bio ANVS Stock Holding History

Paloma Partners’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-17,164	Closed	-$83K	–	1619
2020 Q3	$83K	Buy	+17,164	New	+$91.9K	﹤0.01%	1929

Other funds holding ANVS

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

SIAP

Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return

MWM

Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return

LIG

Lokken Investment Group Lewes, Delaware $291M AUM 13.61% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

SFS

Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

Paloma Partners's ANVS Position: Q4 2020 in Review

Paloma Partners sold out of Annovis Bio (ANVS) in Q4 2020, closing a stake of 17,164 shares — an estimated $83K sold.

Paloma Partners first reported a position in ANVS in Q3 2020 and held it in 1 quarter. The position peaked at $83K in Q3 2020. 13 funds tracked by Wall St. Rank hold ANVS as of Q4 2020.

Paloma Partners reported no remaining Annovis Bio position as of Q4 2020 after selling out during the quarter.
Paloma Partners sold 17,164 Annovis Bio shares in Q4 2020, an estimated $83K.
Paloma Partners first reported a position in Annovis Bio in Q3 2020 and held it in 1 quarter.
Paloma Partners's Annovis Bio position peaked at $83K in Q3 2020.
13 funds tracked by Wall St. Rank held Annovis Bio as of Q4 2020.

Based on Paloma Partners's 13F filing for Q4 2020, filed 16 Feb 2021.